Though the optimum scheme supporting

Though the optimum scheme of supporting therapy is not established yet, these schemes include: кетоконазола перорально on 100 mg a day continuously or on 400 mg within 5 days after менструации итраконазола on 50-100 mg of times day or 200-400 mg of times in a month флюконазола 100 mg week or 150 mg of times in a month клотримазол 500 mg of a candle of times a week or on 200 mg two times a week. In one of clinical рандомизированных researches at treatment of women with рецидивирующим a candidiasis one group received кетоконазол on 400 mg within 14 days. Other group received клотримазол in a kind влагалищных candles on 100 mg within 14 days. In a week after the termination of treatment the success has been reached in both groups more, than in 80 % of cases. In two months in the absence of supporting therapy, at 53 % of women receiving кетоконазол and at 63 % of women receiving клотримазол relapses took place. In other research, relapse within 6 months is noted in control group (плацебо) at 71 %, in the group receiving as supporting therapy кетоконазол cyclically at 29 % and at 5 % of women, receiving кетоконазол is continuous. Weekly use of 0.8 % of a cream терконазола was almost so effective, as well as daily treatment кетоконазолом. Monthly reception of 150 mg флюконазола and итраконазола in a dose of 400 mg reduce frequency of relapses by 50 %.